THE DEVELOPMENT OF TAMOXIFEN FOR BREAST-CANCER THERAPY - A TRIBUTE TO THE LATE WALPOLE,ARTHUR L

被引：119
作者：
JORDAN, VC [1 ]
机构：
[1] UNIV WISCONSIN, DEPT PHARMACOL, MADISON, WI 53792 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1988年 / 11卷 / 03期
关键词：
D O I：
10.1007/BF01807278
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：197 / 209
页数：13
相关论文
共 144 条
  • [1] METABOLISM OF TAMOXIFEN IN HUMANS
    ADAM, HK
    DOUGLAS, EJ
    KEMP, JV
    [J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (01) : 145 - 147
  • [2] MEASUREMENT OF TAMOXIFEN IN SERUM BY THIN-LAYER DENSITOMETRY
    ADAM, HK
    GAY, MA
    MOORE, RH
    [J]. JOURNAL OF ENDOCRINOLOGY, 1980, 84 (01) : 35 - 42
  • [3] ZOLADEX - A SUSTAINED-RELEASE, MONTHLY LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG FOR THE TREATMENT OF ADVANCED PROSTATE-CANCER
    AHMANN, FR
    CITRIN, DL
    DEHAAN, HA
    GUINAN, P
    JORDAN, VC
    KREIS, W
    SCOTT, M
    TRUMP, DL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) : 912 - 917
  • [4] AHMED SR, 1983, LANCET, V2, P415
  • [5] EVIDENCE FOR THE METABOLIC-ACTIVATION OF NON-STEROIDAL ANTIOESTROGENS - A STUDY OF STRUCTURE-ACTIVITY-RELATIONSHIPS
    ALLEN, KE
    CLARK, ER
    JORDAN, VC
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1980, 71 (01) : 83 - 91
  • [6] BAUM M, 1983, LANCET, V1, P257
  • [7] BAUM M, 1985, LANCET, V1, P836
  • [8] Beatson AT, 1896, LANCET, V2, P104
  • [9] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER
    BONADONNA, G
    BRUSAMOLINO, E
    VALAGUSSA, P
    ROSSI, A
    BRUGNATELLI, L
    BRAMBILLA, C
    DELENA, M
    TANCINI, G
    BAJETTA, E
    MUSUMECI, R
    VERONESI, U
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) : 405 - 410
  • [10] BORGNA JL, 1981, J BIOL CHEM, V256, P859
12345678910